FIELD: organic chemistry, chemical technology, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of 4-(phenylpiperazinylmethyl)-benzamide of the general formula (I): or their salt, or separate enantiomers and their salts wherein R1 means phenyl, pyridinyl, thienyl, furanyl, imidazolyl that can be substituted possibly; R2 means ethyl and isopropyl; R3 means hydrogen, fluorine atom; R4 means -NH2, -NHSO2R5 wherein R5 means (C1-C6)-alkyl. Compounds are useful in therapy, in particular, in treatment of pain. Also, invention describes methods for synthesis of compounds of the formula (I) and a pharmaceutical composition based on thereof.
EFFECT: improved method of synthesis, valuable medicinal property of compounds and pharmaceutical composition.
12 cl, 1 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
DERIVATIVES OF INDANE ACETIC ACID AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2314298C2 |
NOVEL COMPOUNDS OF CONDENSED IMIDAZOLE POSSESSING OF CB2 RECEPTOR AGONIST PROPERTY | 2002 |
|
RU2312864C2 |
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
COMPOUNDS OF FORMULA (I) AND FORMULA (A), PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, USE AND METHOD OF OBTAINING COMPOUNDS OF FORMULA (I) | 2018 |
|
RU2822758C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
DERIVATIVES OF 2,4-SUBSTITUTED PHENYLENE-1,5-DIAMINE AND THEIR USES, PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS OBTAINED FROM THEM | 2015 |
|
RU2649001C1 |
DERIVATIVES OF THIOPHENE | 2003 |
|
RU2296758C2 |
6-HETEROCYCLYL-4-MORPHOLINE-4-ILPYRIDINE-2-ONES SUITABLE FOR THE TREATMENT OF CANCER AND DIABETES | 2017 |
|
RU2762968C2 |
Authors
Dates
2007-04-20—Published
2002-05-16—Filed